Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3 Tampa General Cir
Tampa, FL 33606Phone+1 813-745-7585
Summary
- Nikesh Shah, MD, is a Hematologist based in Tampa, FL, specializing in Hematologic Oncology. He completed his medical schooling in 2016 at the University of Miami Leonard M. Miller School of Medicine and pursued his Residency in Internal Medicine at Emory University School of Medicine from 2016 to 2019. Dr. Shah is currently working in malignant hematology at Tampa General Hospital. He has published numerous papers in reputable journals such as Leukemia Research Reports, Leukemia & Lymphoma, JCO Oncology Practice, and Immunotargets and Therapy. His contributions in the field are reflected in the citations his work has received.
Education & Training
- Emory University School of MedicineResidency, Internal Medicine, 2016 - 2019
- University of Miami Leonard M. Miller School of MedicineClass of 2016
Certifications & Licensure
- FL State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 57 citationsImproved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast CancerSimon B. Zeichner, Tulay Koru-Sengul, Nikesh N. Shah, Qingyun Liu, Nathan J. Markward
Clinical Breast Cancer. 2015-02-01 - 12 citationsRacial and Socioeconomic Disparities in Mantle Cell LymphomaNikesh Shah, Yizhao Xi, Yuan Liu, Jean L. Koff, Christopher R. Flowers
Clinical Lymphoma, Myeloma & Leukemia. 2019-06-01 - 25 citationsTargeting CD22 for the Treatment of B-Cell MalignanciesNikesh N. Shah, Lubomir Sokol
Immunotargets and Therapy. 2021-07-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: